Tadawul terminates Morgan Stanley’s market making for Balsm Alofoq, Jana Medical

Logo of Saudi Exchange (Tadawul) 

The Saudi Exchange (Tadawul) approved Morgan Stanley’s request to terminate the market-making deals for Balsm Alofoq Medical Co (9620) and Jana Medical Co (9616).

 

The approval is effective as of Feb. 12, it added in a statement.

 

According to Argaam’s data, Tadawul earlier approved Morgan Stanley Saudi Arabia’s request to conduct market-making activities on Jana as of July 1, 2025, and Balsm Alofoq effective July 15, 2025.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request